We are live on ! Find out more
FMS icon

Fresenius Medical Care

220 hedge funds and large institutions have $779M invested in Fresenius Medical Care in 2017 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 57 increasing their positions, 62 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 26

7% more funds holding

Funds holding: 205220 (+15)

8% less repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 62

1.25% less ownership

Funds ownership: 6.06%4.81% (-1.2%)

15% less capital invested

Capital invested by funds: $912M → $779M (-$133M)

Holders
220
Holders Change
+15
Holders Change %
+7.32%
% of All Funds
4.98%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
42
Increased
57
Reduced
62
Closed
26
Calls
$1.13M
Puts
Net Calls
+$1.13M
Net Calls Change
+$813K

FMS Hedge Fund Activity: Q4 2017 in Review

220 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Fresenius Medical Care (FMS) for Q4 2017, worth a combined $779M — down 15% from $912M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new FMS positions and 26 closed out — a net gain of 16 holders — while 57 added to existing stakes and 62 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $15.1M. The largest seller was Cambiar Investors, cutting an estimated $132M.

  • 220 institutional investors held Fresenius Medical Care (FMS) as of Q4 2017, up from 205 in Q3 2017.
  • Funds reported $779M of Fresenius Medical Care stock for Q4 2017, down 15% quarter-over-quarter.
  • 42 funds opened new Fresenius Medical Care positions in Q4 2017 and 26 closed out, a net change of +16 holders.
  • The largest Fresenius Medical Care buyer in Q4 2017 was Morgan Stanley, an estimated $15.1M added.
  • The largest Fresenius Medical Care seller in Q4 2017 was Cambiar Investors, an estimated $132M sold.

Based on aggregated 13F filings for Q4 2017.